软组织肉瘤术中放疗:ESTRO IORT工作组/ACROP推荐
ESTRO IORT工作组/ACROP专家组通过系统文献综述并结合临床经验,制定了软组织肉瘤术中放疗(IORT)的指南。推荐涵盖患者选择、多学科整合及IORT操作流程;含IORT方案在肢体和腹膜后软组织肉瘤中可获得高局部控制率和低至可接受的毒性。
要点
- IORT含有的方案在肢体软组织肉瘤中局部控制率高、急慢性毒性低。
- 腹膜后肉瘤随机试验支持IORT联合中等剂量术后EBRT优于单纯高剂量术后EBRT。
- 指南涵盖患者选择、照射体积、剂量处方、记录报告及治疗实施等环节。
核心结论
- 含IORT的方案可获得高局部控制率,毒性低至可接受。
- 基于现有证据,专家组制定了软组织肉瘤IORT使用推荐。
研究设计与样本
- ESTRO IORT工作组/ACROP专家组进行系统文献综述并结合临床经验制定推荐。
- 证据来源包括肢体软组织肉瘤的小型前瞻性研究和主要为回顾性单中心研究。
- 腹膜后肉瘤证据来自一项前瞻性随机试验、少数前瞻性研究及大量回顾性研究。
主要发现
- 肢体软组织肉瘤中,含IORT方案局部控制率很高,急性和晚期毒性发生率低。
- 腹膜后肉瘤随机试验比较IORT联合中等剂量术后EBRT与单纯高剂量术后EBRT,结果明显支持含IORT方案。
- 前瞻性和回顾性研究证实腹膜后肉瘤含IORT方案局部控制率高、毒性可接受,主要支持术前EBRT联合IORT。
关键数值与推荐
- 推荐涉及患者选择、纳入多模式治疗概念及IORT操作本身。
- 定义了手术因素、照射体积、技术要求、剂量处方、记录与报告、治疗实施及IORT期间护理。
- 涵盖软组织肉瘤治疗所用的主要IORT技术。
临床怎么用
- 临床医生可在常规实践中参照本指南使用IORT治疗软组织肉瘤。
- 研究者可在未来试验设计中采用这些推荐。
局限性
- 肢体软组织肉瘤证据来自少数小型前瞻性研究及主要为回顾性单中心研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To describe guidelines for the use of intraoperative radiation therapy (IORT) in the treatment of soft-tissue sarcomas (STS). METHODS: A panel of experts in the field performed a systematic literature review, supplemented their clinical experience and developed recommendations for the use of IORT in the treatment of STS. RESULTS: Based on the evidence from the systematic literature review and the clinical experience of the panel members, recommendations regarding patient selection, incorporation into multimodal treatment concepts and the IORT procedure itself are made. The rationale for IORT in extremity and retroperitoneal STS is summarized and results of the major series in terms of patient and treatment characteristics, oncological outcome and toxicity are presented. We define surgical factors, volumes for irradiation, technical requirements, dose prescription, recording and reporting, treatment delivery and care during the course of IORT covering the main IORT techniques used for the treatment of STS. In extremity STS, evidence originates from a few small prospective and mainly from retrospective single centre studies. Based on those reports, IORT containing-approaches result in very high local control rates with low rates of acute and late toxicity. In retroperitoneal sarcomas, evidence is derived from one prospective randomized trial, a few prospective and a large number of retrospective studies. The randomized trial compared IORT combined with moderate doses of postoperative external-beam radiation therapy (EBRT) to high-dose postoperative EBRT alone after gross total resection, clearly favouring the IORT-containing approach. These results have been confirmed by the prospective and retrospective studies, which similarly showed high local control rates with acceptable toxicity, mainly favouring combinations of preoperative EBRT and IORT. CONCLUSIONS: IORT-containing approaches result in high rates of local control with low to acceptable toxicity rates. Based on the available evidence, we made recommendations for the use of IORT in STS. Clinicians and researchers are encouraged to use these guidelines in clinical routine as well as in the design of future trials.
引用
- Roeder F, Morillo V, Saleh-Ebrahimi L, et al. Intraoperative radiation therapy (IORT) for soft tissue sarcoma - ESTRO IORT Task Force/ACROP recommendations. Radiother Oncol. 2020. PMID: 32679306. doi:10.1016/j.radonc.2020.07.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。